Compounds > ipodate
Page last updated: 2024-08-16

ipodate and sulfobromophthalein

ipodate has been researched along with sulfobromophthalein in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Czanko, R; Felicetta, JV; Huber-Smith, MJ; McCann, DS1
Felicetta, JV; Green, WL; Huber-Smith, MJ1
Felicetta, JV; Green, WL; Nelp, WB1

Other Studies

4 other study(ies) available for ipodate and sulfobromophthalein

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Cholecystographic agents and sulfobromophthalein inhibit the binding of L-thyroxine to plasma membranes of rat hepatocytes.
    Endocrinology, 1986, Volume: 118, Issue:6

    Topics: Animals; Binding, Competitive; Cell Membrane; Cholecystography; Contrast Media; Female; Iopanoic Acid; Ipodate; Liver; Rats; Rats, Inbred Strains; Sulfobromophthalein; Thyroxine; Tyropanoate

1986
Effects of cholecystographic agents and sulfobromophthalein on binding of thyroid hormones to serum proteins.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:1

    Topics: Blood Proteins; Contrast Media; Humans; In Vitro Techniques; Iopanoic Acid; Ipodate; Kinetics; Male; Protein Binding; Sulfobromophthalein; Thyroxine; Triiodothyronine; Tyropanoate

1983
Inhibition of hepatic binding of thyroxine by cholecystographic agents.
    The Journal of clinical investigation, 1980, Volume: 65, Issue:5

    Topics: Adult; Cholecystography; Contrast Media; Female; Humans; Ipodate; Liver; Male; Middle Aged; Sulfobromophthalein; Thyroxine; Tyropanoate

1980